| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/14/2010 | CN101773612A Chinese medicine composition for increasing weight of pig |
| 07/14/2010 | CN101773565A Preparation and feeding active function of compound Chinese herbal medicine |
| 07/14/2010 | CN101229157B Calldesartan ci1exetil medicine compounds |
| 07/13/2010 | USRE41439 Pharmaceutical compositions and methods for use |
| 07/13/2010 | US7754864 Tyrosinase activity controlling agent, process for producing the same and external preparation containing the same |
| 07/13/2010 | US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 07/13/2010 | US7754774 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 07/13/2010 | US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction |
| 07/13/2010 | US7754757 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes |
| 07/13/2010 | US7754751 Preferential inhibition of release of pro-inflammatory cytokines |
| 07/13/2010 | US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12) |
| 07/13/2010 | US7754743 Heteroarylcarbamoylbenzene derivatives |
| 07/13/2010 | US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2) |
| 07/13/2010 | US7754728 Adenine compound and use thereof |
| 07/13/2010 | US7754716 vatalanib succinate (PTK787) and temozolomide; glioblastomas |
| 07/13/2010 | US7754678 fusion proteins; drug delivery |
| 07/13/2010 | US7754459 having an amino acid sequence which has a functional NAD+ binding domain and no PARP zinc finger sequence motifs |
| 07/13/2010 | US7754434 by measuring the concentration of a brain-derived neurotrophic factor in blood of the patients; anorexia and bulimia nervosa |
| 07/13/2010 | US7754422 Method of judging inflammatory disease |
| 07/13/2010 | US7754250 Drugs comprising plant extracts used for prevention amyloid formation, deposition or accumulation; amyloid fibrils, amylin fibrils, or islet amyloid fibrils or pre-deposited amyloid fibrils in type II diabetes; amyloid inhibitor |
| 07/13/2010 | US7754217 HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/13/2010 | US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient |
| 07/13/2010 | US7754200 Phosphate transport inhibitors |
| 07/13/2010 | CA2500888C Isoquinoline compounds and medicinal use thereof |
| 07/13/2010 | CA2457451C Naphthyridine derivatives |
| 07/13/2010 | CA2448303C Biologically active methylene blue derivatives |
| 07/13/2010 | CA2446820C Novel pyrrole derivatives as pharmaceutical agents |
| 07/13/2010 | CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 07/13/2010 | CA2444535C Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 07/13/2010 | CA2443135C Pharmaceutically active compounds and methods of use |
| 07/13/2010 | CA2440979C Spirolaximes for use in the treatment of pathologies that respond to ppar-.gamma. receptor activation |
| 07/13/2010 | CA2432145C Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/13/2010 | CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 07/13/2010 | CA2420350C Membrane penetrating peptides and uses thereof |
| 07/13/2010 | CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/13/2010 | CA2388754C Therapeutic intervention to mimic the effect of caloric restriction |
| 07/13/2010 | CA2374659C N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and agents for treating neurodegenerative diseases comprising the same |
| 07/13/2010 | CA2356533C Inhibitors of the bitter taste response |
| 07/13/2010 | CA2347713C Contulakin-g, analogs thereof and uses therefor |
| 07/13/2010 | CA2345932C Peptide-based carrier devices for stellate cells |
| 07/13/2010 | CA2176742C Composition for the in vivo production of therapeutic products |
| 07/08/2010 | WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | WO2010076884A1 Novel fused ring compound and use thereof |
| 07/08/2010 | WO2010076496A1 Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system |
| 07/08/2010 | WO2010075861A2 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof |
| 07/08/2010 | WO2010039510A3 Use of syndyphalin-33 (sd-33; try-dmet(o)-gly-methylphenylethylamide) as a therapeutic agent to enhance the health and well-being of newly-weaned animals |
| 07/08/2010 | US20100175141 Tunable genetic switch for regulating gene expression |
| 07/08/2010 | US20100174076 Coumarin derivatives useful as tnf alpha inhibitors |
| 07/08/2010 | US20100174056 Recombinant tumor specific antibody and use thereof |
| 07/08/2010 | US20100173976 RNA INTERFERENCE MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/08/2010 | US20100173969 Therapeutic agent |
| 07/08/2010 | US20100173951 Novel methods |
| 07/08/2010 | US20100173946 Benzimidazolylidene propane-1,3-dione derivative or salt thereof |
| 07/08/2010 | US20100173922 Polymorphisms for Predicting Disease and Treatment Outcome |
| 07/08/2010 | US20100173881 Compositions for the treatment of inflammatory disorders |
| 07/08/2010 | US20100173870 Phosphonate Compounds |
| 07/08/2010 | US20100173859 Pharmaceutical formulation for the production of rapidly disintergrating tablets |
| 07/08/2010 | US20100173855 Dermatological Formulations |
| 07/08/2010 | US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 07/08/2010 | US20100173839 Stabilized insulin-like growth factor polypeptides |
| 07/08/2010 | US20100173327 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/08/2010 | US20100172997 Gold, silver, and copper nanoparticles stabilized in biocompatible aqueous media |
| 07/08/2010 | US20100172990 Biocompatible microgels and applications thereof |
| 07/08/2010 | US20100172952 Electrospun Scaffolds And Methods Of Generating And Using Same |
| 07/08/2010 | US20100172951 Enhanced Medical Implant |
| 07/08/2010 | US20100172949 Consensus peptide |
| 07/08/2010 | US20100172915 Compositions and methods of using angiopoietin-like 4 protein |
| 07/08/2010 | US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/08/2010 | US20100172909 Cerebral edema suppressant |
| 07/08/2010 | US20100172905 Antagonists of hmg1 for treating inflammatory conditions |
| 07/08/2010 | US20100172896 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/08/2010 | US20100172894 Methods for purification of single domain antigen binding molecules |
| 07/08/2010 | US20100172889 Degradable biomolecule compositions |
| 07/08/2010 | CA2748562A1 Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system |
| 07/08/2010 | CA2747310A1 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof |
| 07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/07/2010 | EP2204365A1 Alkylsulfone derivative |
| 07/07/2010 | EP2204360A1 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient |
| 07/07/2010 | EP2204192A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | EP2204176A2 Nutritional Composition |
| 07/07/2010 | EP2203167A1 Compound and use thereof in the treatment of amyloidosis |
| 07/07/2010 | EP2203061A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 07/07/2010 | EP1900811B1 Enriched central nervous system cell populations |
| 07/07/2010 | EP1491537B1 Hydroxymorpholinone derivative and medicinal use thereof |
| 07/07/2010 | EP1487806B1 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | EP1418941B1 Inducted immune response against the feline immunodeficiency virus |
| 07/07/2010 | EP1392301B1 Prevention of addiction in pain management with gamma vinyl gaba |
| 07/07/2010 | EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 07/07/2010 | CN1674863B Antiaging composition |
| 07/07/2010 | CN101766624A Application of Morphine as medicament for promoting growth of PC12 cells |
| 07/07/2010 | CN101766623A Application of Morphine as antioxidant stress injury agent |
| 07/07/2010 | CN101766605A Pramipexole-contained pharmaceutical composition capable of being dispersed in mouth |
| 07/07/2010 | CN101766258A Traditional Chinese medicinal composition and application thereof as pig feed additive |
| 07/07/2010 | CN101213952B Method for producing low cholesterol egg without residual agricultural chemical |
| 07/06/2010 | US7750150 Process for producing acid adduct salt of polyacidic base compound |
| 07/06/2010 | US7750133 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 07/06/2010 | US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 07/06/2010 | US7750041 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents |